ONC vs RPRX: Fair Value Comparison

BeiGene, Ltd. vs. Royalty Pharma Plc · Biotechnology

ONC's model fair value sits 31.9% below its current price; RPRX's model fair value sits 32.1% below its current price. Of the two, ONC trades further below its model estimate. Model estimates under stated assumptions. Data as of 2026-10-22.

ONCRPRX
Price$380.00$63.96
Model fair value (multi-method blend)$258.78$43.42
Model fair value differential-31.9%-32.1%
Methods with a model value above price9 of 106 of 8
Fundamental strengthB+B
Next earnings report2026-11-052026-11-04

Differential = model fair value versus the current price; positive means the price sits below the model estimate.

More comparisons

VRTX vs ONC · REGN vs ONC · ARGX vs ONC · ONC vs ALNY · VRTX vs RPRX · REGN vs RPRX · ARGX vs RPRX · RPRX vs ALNY · All Biotechnology stocks · Compare any two stocks